169 related articles for article (PubMed ID: 7526568)
21. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S
Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487
[TBL] [Abstract][Full Text] [Related]
22. Induction of immune responses by two recombinant proteins of brucella abortus, outer membrane proteins 2b porin and Cu/Zn superoxide dismutase, in mouse model.
Sung KY; Jung M; Shin MK; Park HE; Lee JJ; Kim S; Yoo HS
J Microbiol Biotechnol; 2014 Jun; 24(6):854-61. PubMed ID: 24608566
[TBL] [Abstract][Full Text] [Related]
23. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
[TBL] [Abstract][Full Text] [Related]
24. Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.
Retamal-Díaz A; Riquelme-Neira R; Sáez D; Rivera A; Fernández P; Cabrera A; Guzmán CA; Oñate A
Clin Vaccine Immunol; 2014 Nov; 21(11):1474-80. PubMed ID: 25165025
[TBL] [Abstract][Full Text] [Related]
25. Substantial Protective Immunity Conferred by a Combination of
Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
[TBL] [Abstract][Full Text] [Related]
26. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.
Singha H; Mallick AI; Jana C; Isore DP; Goswami TK; Srivastava SK; Azevedo VA; Chaudhuri P; Owais M
Microbes Infect; 2008; 10(10-11):1089-96. PubMed ID: 18602490
[TBL] [Abstract][Full Text] [Related]
27. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
28. Protective efficacy of a canine brucellosis vaccine candidate based on live attenuated Salmonella expressing recombinant Brucella BCSP31, Omp3b and SOD proteins in Beagles.
Kim WK; Moon JY; Cho JS; Park BY; Hur J
J Vet Med Sci; 2018 Sep; 80(9):1373-1379. PubMed ID: 30068897
[TBL] [Abstract][Full Text] [Related]
29. Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice.
Truong QL; Cho Y; Park S; Park BK; Hahn TW
Microb Pathog; 2016 Jun; 95():175-185. PubMed ID: 27057678
[TBL] [Abstract][Full Text] [Related]
30. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.
Yu DH; Hu XD; Cai H
DNA Cell Biol; 2007 Jun; 26(6):435-43. PubMed ID: 17570767
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.
Winter AJ; Rowe GE; Duncan JR; Eis MJ; Widom J; Ganem B; Morein B
Infect Immun; 1988 Nov; 56(11):2808-17. PubMed ID: 2844673
[TBL] [Abstract][Full Text] [Related]
32. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection.
Oliveira SC; Splitter GA
Vaccine; 1996 Jul; 14(10):959-62. PubMed ID: 8873388
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of Brucella abortus salt-extractable proteins.
Tabatabai LB; Deyoe BL; Patterson JM
Vet Microbiol; 1989 May; 20(1):49-58. PubMed ID: 2503922
[TBL] [Abstract][Full Text] [Related]
34. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide-dismutase: II. Induction of specific CD8+ cytotoxic lymphocytes and sensitized CD4+ IFN-gamma-producing cell.
Andrews E; Salgado P; Folch H; Oñate A
Microbiol Immunol; 2006; 50(5):389-93. PubMed ID: 16714846
[TBL] [Abstract][Full Text] [Related]
36. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
Goel D; Rajendran V; Ghosh PC; Bhatnagar R
Vaccine; 2013 Feb; 31(8):1231-7. PubMed ID: 23273966
[TBL] [Abstract][Full Text] [Related]
37. Effect of Brucella abortus transfer factor in preventing murine brucellosis.
Stevens MG; Pugh GW
FEMS Immunol Med Microbiol; 1995 Jul; 11(4):279-84. PubMed ID: 8541805
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of DNA vaccine encoding BCSP
Imtiaz W; Khan A; Gul ST; Saqib M; Saleemi MK; Shahzad A; Dong J; Hussain R; Shen M; Du X
Microb Pathog; 2018 Dec; 125():514-520. PubMed ID: 30321591
[TBL] [Abstract][Full Text] [Related]
39. Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus.
Pratt AJ; DiDonato M; Shin DS; Cabelli DE; Bruns CK; Belzer CA; Gorringe AR; Langford PR; Tabatabai LB; Kroll JS; Tainer JA; Getzoff ED
J Bacteriol; 2015 Dec; 197(24):3834-47. PubMed ID: 26459556
[TBL] [Abstract][Full Text] [Related]
40. Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines.
Vemulapalli R; He Y; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2002 Dec; 90(1-4):521-32. PubMed ID: 12414168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
